Search

Author/Creator Piovesan, D.

1. AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, leads to greater immune activation and reduced tumor growth when combined with chemotherapy. (March 2018)

Authors:
Schindler, U.; Seitz, L.; Ashok, D.; Piovesan, D.; Tan, J.; DiRenzo, D.; Yin, F.; Leleti, M.; Rosen, B.; Miles, D.; Jin, L.; Park, T.; Young, S.; Soriano, F.; Rieger, A.; Karakunnel, J.; Sharif, E.; Powers, J.P.; Walters, M.J.
Journal:
European journal of cancer
Issue:
Volume 92(2018)Supplement 1
Page Start:
S14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Discovery and characterization of novel, potent, and selective hypoxiainducible factor (HIF)-2α inhibitors. (October 2020)

Authors:
Lawson, K.; Gauthier, K. Sivick; Piovesan, D.; Fournier, J.; Rosen, B.; Maliyan, A.; Beatty, J.; Jin, L.; Leleti, M.; Ginn, E.; Udyavar, A.; Ada, C.; Au, J.; Meleza, C.; Zhao, S.; Young, S.; Walters, M.; Powers, J.
Journal:
European journal of cancer
Issue:
Volume 138(2020)Supplement 2
Page Start:
S16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search